Duke University-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Duke University-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH43944D
  • |
  • Pages: 49
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Duke University (Duke) is an educational consulting institution that offers in-business and graduation services. The institution provides education and graduation services through its schools and institutes. Its educational fields include in divinity, business, the environment, engineering, medicine, law, nursing, public policy and others. Duke's services include technology administration, human resource services, transportation, dining, safety and security; finance, stores, campus services, academic services and other facilities. The institute's transportation services include buses, parking and permits; van operations, alternative transportation, disability management and map services. It also conducts activities including basketball, lacrosse and soccer, and women's golf and tennis, and research on marine biotechnology and biomedicine. The institution provides research support services. Duke is headquartered in Durham, North Carolina, the US.

Duke University-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Duke University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Duke University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Duke University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Duke University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Duke University, Medical Devices Deals, 2011 to YTD 2017 10

Duke University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

Duke University, Pharmaceuticals & Healthcare, Deal Details 13

Partnerships 13

DelMar Pharma Enters into Partnership with Duke University 13

Tempus Labs Enters into Agreement with Duke University School of Medicine 13

Immunomic Therapeutics Enters into Research Agreement with Duke University 14

Nuevolution Enters Into Agreement With Howard Hughes Medical Institute, Lexicon Pharma And Duke University For Drug Discovery 15

CellepathicRx Forms Joint Venture With Duke University 16

VistaGen Therapeutics Enters Into Research Agreement With Duke University 17

Bristol-Myers Squibb Enters Into Co-Development Agreement With Duke Translational Medicine Institute 17

Angion Biomedica Enters Into Co-Development Agreement With Duke University And Massachusetts General Hospital 18

Duke Human Vaccine Institute Enters Into Research Agreement With Novartis Vaccines 19

Aeolus Pharma Enters into Research Agreement with Duke University 21

Duke University Health Forms Joint Venture With LifePoint Hospitals 21

Licensing Agreements 22

Enzyvant Sciences Enters into Licensing Agreement with Duke University 22

Sermonix Pharma Enters into Licensing Agreement with Duke University 23

Cocrystal Pharma Enters into Licensing Agreement with Duke University and Emory University 24

Annias Immunotherapeutics Enters into Licensing Agreement with Duke Cancer Institute 25

Editas Medicine Enters into Licensing Agreement with Duke University 26

Duke University Enters into Licensing Agreement with PhaseBio Pharma 26

Medifocus Enters into Licensing Agreement with Duke University 27

Trovagene Enters Into Licensing Agreement With Duke University And Duke University Health Systems For NPM1 Marker 28

BioMimetix Enters Into Licensing Agreement With Duke University 29

Celsion Enters Into Licensing Agreement With Duke University 29

Duke University-Key Competitors 31

Key Employees 32

Locations And Subsidiaries 33

Head Office 33

Other Locations & Subsidiaries 33

Recent Developments 36

Government and Public Interest 36

Mar 13, 2017: University Of Utah Engineers Use CRISPR Technology To Prevent Tissue Damage And Resulting Chronic Pain 36

Nov 30, 2016: Drug Delivery Modification Sidesteps Allergic Responses 37

Sep 30, 2016: NHLBI Awards Grants to Help Improve Health Outcomes for Teens, Adults with Sickle Cell Disease 39

Sep 22, 2016: Kenneth Rainin Foundation Awards Over $3 Million to High-Risk, High Reward Inflammatory Bowel Disease Research Projects 40

Mar 04, 2016: Geisinger physician participating in PCORI-sponsored study on patient-centered kidney care 42

Jan 07, 2016: Slow stem cell division may cause small brains 43

Product News 44

Dec 08, 2016: Scientists develop new drug screening tool for dystonia 44

Jun 01, 2016: Scientists Discover and Test New Class of Pain Relievers 46

Other Significant Developments 47

Jun 21, 2016: New Program launches to address North Carolina's shortage of Primary Care Physicians 47

Appendix 49

Methodology 49

About GlobalData 49

Contact Us 49

Disclaimer 49

List of Figures

Duke University, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Duke University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Duke University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Duke University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Duke University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Duke University, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

Duke University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Duke University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Duke University, Medical Devices Deals, 2011 to YTD 2017 10

List of Tables

Duke University, Pharmaceuticals & Healthcare, Key Facts 1

Duke University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Duke University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Duke University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Duke University, Deals By Therapy Area, 2011 to YTD 2017 9

Duke University, Medical Devices Deals, 2011 to YTD 2017 10

Duke University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

DelMar Pharma Enters into Partnership with Duke University 13

Tempus Labs Enters into Agreement with Duke University School of Medicine 13

Immunomic Therapeutics Enters into Research Agreement with Duke University 14

Nuevolution Enters Into Agreement With Howard Hughes Medical Institute, Lexicon Pharma And Duke University For Drug Discovery 15

CellepathicRx Forms Joint Venture With Duke University 16

VistaGen Therapeutics Enters Into Research Agreement With Duke University 17

Bristol-Myers Squibb Enters Into Co-Development Agreement With Duke Translational Medicine Institute 17

Angion Biomedica Enters Into Co-Development Agreement With Duke University And Massachusetts General Hospital 18

Duke Human Vaccine Institute Enters Into Research Agreement With Novartis Vaccines 19

Aeolus Pharma Enters into Research Agreement with Duke University 21

Duke University Health Forms Joint Venture With LifePoint Hospitals 21

Enzyvant Sciences Enters into Licensing Agreement with Duke University 22

Sermonix Pharma Enters into Licensing Agreement with Duke University 23

Cocrystal Pharma Enters into Licensing Agreement with Duke University and Emory University 24

Annias Immunotherapeutics Enters into Licensing Agreement with Duke Cancer Institute 25

Editas Medicine Enters into Licensing Agreement with Duke University 26

Duke University Enters into Licensing Agreement with PhaseBio Pharma 26

Medifocus Enters into Licensing Agreement with Duke University 27

Trovagene Enters Into Licensing Agreement With Duke University And Duke University Health Systems For NPM1 Marker 28

BioMimetix Enters Into Licensing Agreement With Duke University 29

Celsion Enters Into Licensing Agreement With Duke University 29

Duke University, Key Competitors 31

Duke University, Key Employees 32

Duke University, Other Locations 33

Duke University, Subsidiaries 33

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Duke University, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16040
Site License
USD 500 INR 32080
Corporate User License
USD 750 INR 48120

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com